Hematologic Malignancies Testing Industry Drivers, Demand, Merger, Acquisition, SWOT Analysis, PESTELE Analysis and Business Opportunities by 2027
The rising prevalence of Leukemia and Multiple myeloma and the increasing awareness among patients and healthcare professionals about initial diagnosis are driving the demand for the market.
View full press release